Aspect Biosystems is pioneering the development of bioprinted tissue therapeutics designed to replace, repair, or supplement biological function inside the body. The company’s current therapeutic pipeline is focused on metabolic and endocrine diseases such as diabetes, obesity, and congenital liver disorders.